[Unexpected Complications in the Withdrawal Treatment of the Research Chemical AH-7921]

Fortschr Neurol Psychiatr. 2016 Oct;84(S 02):S80-S83. doi: 10.1055/s-0042-113960. Epub 2016 Nov 2.
[Article in German]

Abstract

We describe the case of a young male patient who had consumed the morphine-like substance AH-7921 which is available via the internet. He was initially admitted to hospital because of obstipation and presented within a day of inpatient treatment for the first time with a generalized tonic-clonic epileptic seizure with subsequent urinary retention. Within a few hours, the patient then also developed bradycardia, while at the same time describing symptoms of physical opioid withdrawal which gradually deteriorated within the following hours. We initiated a treatment with buprenorphine which resulted in a considerable reduction of withdrawal symptoms, so the patient could be discharged from hospital.

Publication types

  • Case Reports

MeSH terms

  • Analgesics, Opioid / adverse effects*
  • Benzamides / adverse effects*
  • Buprenorphine / therapeutic use
  • Epilepsy, Tonic-Clonic / etiology
  • Epilepsy, Tonic-Clonic / therapy
  • Humans
  • Male
  • Narcotic Antagonists / therapeutic use
  • Substance Withdrawal Syndrome / therapy*
  • Urinary Retention / chemically induced
  • Urinary Retention / therapy
  • Young Adult

Substances

  • Analgesics, Opioid
  • Benzamides
  • Narcotic Antagonists
  • Buprenorphine
  • AH 7921